<SEC-DOCUMENT>0001078782-13-002117.txt : 20131104
<SEC-HEADER>0001078782-13-002117.hdr.sgml : 20131104
<ACCEPTANCE-DATETIME>20131104145952
ACCESSION NUMBER:		0001078782-13-002117
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20131104
ITEM INFORMATION:		Other Events
FILED AS OF DATE:		20131104
DATE AS OF CHANGE:		20131104

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			OphthaliX, Inc.
		CENTRAL INDEX KEY:			0001218683
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				880445169
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-52545
		FILM NUMBER:		131188769

	BUSINESS ADDRESS:	
		STREET 1:		1656 REUNION AVENUE
		STREET 2:		SUITE 250
		CITY:			SOUTH JORDAN
		STATE:			UT
		ZIP:			84095
		BUSINESS PHONE:		801-446-8802

	MAIL ADDRESS:	
		STREET 1:		1656 REUNION AVENUE
		STREET 2:		SUITE 250
		CITY:			SOUTH JORDAN
		STATE:			UT
		ZIP:			84095

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DENALI CONCRETE MANAGEMENT INC
		DATE OF NAME CHANGE:	20030213
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>f8k110413_8k.htm
<DESCRIPTION>FORM 8-K CURRENT REPORT
<TEXT>
<!doctype html public "-//IETF//DTD HTML//EN">
<HTML>
<HEAD>
<TITLE>FORM 8-K Current Report</TITLE>
<META NAME="author" CONTENT="Eric Chess Bronk">
<META NAME="date" CONTENT="11/04/2013">
</HEAD>
<BODY style="margin-top:0;font-family:Times New Roman; font-size:10pt; color:#000000">
<DIV style="width:624px"><P style="margin:0px" align=center><BR></P>
<P style="margin:0px" align=center><B>UNITED STATES</B></P>
<P style="margin:0px" align=center><B>SECURITIES AND EXCHANGE COMMISSION</B></P>
<P style="margin:0px" align=center><B>WASHINGTON, D.C. &nbsp;20549</B></P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px; font-size:14pt" align=center><B>FORM 8-K</B></P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px" align=center>CURRENT REPORT</P>
<P style="margin:0px" align=center>PURSUANT TO SECTION 13 OR 15(d) OF THE</P>
<P style="margin:0px" align=center>SECURITIES EXCHANGE ACT OF 1934</P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px" align=center>Date of report (Date of earliest event reported) &nbsp;&nbsp;<B>November 4, 2013</B></P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px; font-size:18pt" align=center><B>OphthaliX Inc.</B></P>
<P style="margin:0px" align=center>(Exact Name of Registrant as Specified in its Charter)</P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px" align=center><BR></P>
</DIV><TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0><TR height=0 style="font-size:0"><TD width=212.8 /><TD width=212.8 /><TD width=205.6 /></TR>
<TR><TD style="margin-top:0px" valign=top width=212.8><P style="margin:0px" align=center><B>Delaware</B></P>
</TD><TD style="margin-top:0px" valign=top width=212.8><P style="margin:0px" align=center><B>000-52545</B></P>
</TD><TD style="margin-top:0px" valign=top width=205.6><P style="margin:0px" align=center><B>88-0445169</B></P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=212.8><P style="margin:0px" align=center>(State or Other Jurisdiction </P>
<P style="margin:0px" align=center>of Incorporation)</P>
</TD><TD style="margin-top:0px" valign=top width=212.8><P style="margin:0px" align=center>(Commission File Number)</P>
</TD><TD style="margin-top:0px" valign=top width=205.6><P style="margin:0px" align=center>(IRS Employer </P>
<P style="margin:0px" align=center>Identification No.)</P>
</TD></TR>
</TABLE>
<DIV style="width:624px"><P style="margin:0px" align=center><BR></P>
<P style="margin:0px" align=center><BR></P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 align=center><TR height=0 style="font-size:0"><TD width=271.2 /><TD width=114 /></TR>
<TR><TD style="margin-top:0px" valign=top width=271.2><P style="margin:0px" align=center><B>10 Bareket Street, Petach Tikva, Israel</B></P>
</TD><TD style="margin-top:0px" valign=top width=114><P style="margin:0px" align=center><B>4951778</B></P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=271.2><P style="margin:0px" align=center>(Address of Principal Executive Offices)</P>
</TD><TD style="margin-top:0px" valign=top width=114><P style="margin:0px" align=center>(Zip Code)</P>
</TD></TR>
</TABLE>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px" align=center>Registrant&#146;s telephone number, including area code: &nbsp;<B>+(972) 3-9241114</B></P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px" align=justify>Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px">&nbsp;<FONT style="margin-bottom:1.333px; padding-top:1.333px; font-size:6pt; border:1px solid #000000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT style="font-size:6pt; color:#FFFFFF">.</FONT> Written communications pursuant to Rule 425 under the Securities Act</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px">&nbsp;<FONT style="margin-bottom:1.333px; padding-top:1.333px; font-size:6pt; border:1px solid #000000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT style="font-size:6pt; color:#FFFFFF">.</FONT> Soliciting material pursuant to Rule 14a-12 under the Exchange Act</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; padding-left:48px; text-indent:-48px">&nbsp;<FONT style="margin-bottom:1.333px; padding-top:1.333px; font-size:6pt; border:1px solid #000000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT style="font-size:6pt; color:#FFFFFF">.</FONT> Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; padding-left:48px; text-indent:-48px">&nbsp;<FONT style="margin-bottom:1.333px; padding-top:1.333px; font-size:6pt; border:1px solid #000000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT style="font-size:6pt; color:#FFFFFF">.</FONT> Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify><BR>
<BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:96px; float:left"><B>Item 8.01</B></P>
<P style="margin:0px; text-indent:-2px" align=justify><B>Other Events.</B></P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin:0px" align=justify>On November 4, 2013, the Company provided an update that it anticipates that during the first quarter of 2014 it will initiate enrolment for its Phase II trial of CF101 for the treatment of uveitis.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=center><B>SIGNATURES</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; padding-left:336px"><B>OphthaliX Inc.</B></P>
<P style="margin:0px"><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:336px; float:left">Date: &nbsp;November 4, 2013</P>
<P style="margin:0px; padding-left:336px; text-indent:-2px">By: <I><U>/s/ Barak Singer</U></I></P>
<P style="margin:0px; padding-left:336px; clear:left">Barak Singer, Chief Executive Officer</P>
<P style="margin:0px"><BR>
<BR></P>
<P style="margin:0px" align=center>2</P>
<P style="margin:0px"><BR></P>
</DIV></BODY>
<!-- EDGAR Validation Code: 1D8F1956 -->
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
